The inconsistencies and conflicts between recommendations, along with the clinician’s necessity to control AS disease activity, have led many physicians in our registry to individually resume TNF inhibitors in AS patients who have been diagnosed as having active tuberculosis. Here, TNF is linked to tuberculosis.